SUMMARY The gastric acid, pepsin, and secretory volume output in response to a mixed meal were measured in six patients with Zollinger-Ellison syndrome caused by a gastrin-producing tumour proved subsequently at surgery. The patients were all normocalcaemic, and none had previous abdominal surgery. In four of the six patients, ingestion of the meal markedly inhibited the gastric secretory output, which decreased to below fasting levels, returning later to basal values. In two other patients, whose fasting acid output was considerably lower, the secretory output increased after the meal, but some inhibition of gastric secretion was also apparent for variable intervals of time. The serum gastrin concentration in all patients remained essentially unchanged or increased after the meal. Two patients were restudied after successful removal of the duodenal gastrin-producing tumour, and in each the normal gastric secretory and gastrin-releasing responses were completely restored. Our studies suggest that, in patients with the Zollinger-Ellison syndrome caused by a gastrinoma, physiological regulatory mechanisms triggered by food reduce the continuous stimulation of gastric secretion caused by their tumoural hypergastrinaemia.
The gastric secretory response to meals in the Zollinger-Ellison (Z-E) syndrome was studied in order to observe: (1) the effects of sustained, endogenous hypergastrinaemia on postprandial gastric function, and (2) interactions between hypergastrinaemia and other neurohormonal mechanisms activated by ingestion of food. By a method previously developed and validated (Malagelada et al., 1976b) , we measured gastric secretory responses to a mixed meal in a group of six patients with gastrinoma; two of the six were also studied after successful excision of the gastrin-producing tumour.
Methods

PATIENTS
The six patients with the Z-E syndrome fulfilled the criteria of fasting gastric hyperchlorhydria (Figs. 1 and 2), hypergastrinaemia (Table 1) , and biopsy-'Supported in part by Grant AM-6908 from the National Institutes of Health.
'Address for reprint requests: Dr J.-R. Malagelada, Mayo Clinic, Rochester, MN 55901, USA. Received for publication 19 October 1977 proved diagnosis of endocrine-type tumour at surgery. All six patients were normocalcaemic, and none had previous abdominal surgery. No patient had clinical or radiographic evidence of gastric outlet obstruction, and none was receiving anticholinergic drugs or H2-receptor inhibitor drugs. The use of oral neutralising antacids was stopped at least six hours before the study was started. Our investigations began after securing approval from the Mayo Clinic Human Studies Committee (23 March 1974) , and informed consent was also obtained from every patient. The patients' clinical histories and laboratory data are summarised in Table 2 . Subsequent follow-up of case I (up to nine months) and of case 2 (up to three years), who were restudied after excision of their gastrin-secreting tumours, has revealed no recurrence of hypergastrinaemia, gastric hypersecretion, or clinical symptoms. , 1973) . Calculations previously described in detail were employed to obtain postprandial gastric acid, pepsin, and total secretory volume outputs (Malagelada et al., 1976b) . Peak postprandial secretory outputs were calculated by doubling the sum of the three consecutive highest 10-minute outputs, and lowest postprandial secretory outputs were estimated by doubling the sum of the three consecutive lowest 10-minute outputs (Table 3) . Two patients, whose tumours were resected and whose fasting serum gastrin levels returned to normal after the procedure, were restudied after the fourth postoperative week.
MEASUREMENT OF BASAL AND PEAK(BETA-ZOLE-STIMULATED) GASTRIC ACID OUTPUT
On a separate day, 'basal' acid output and 'maximal' response to betazole (Isenberg, 1973) were determined by the standard method of continuous gastric perfusion (Malagelada et al., 1976a ) employing 51CrC13 as a recovery marker. After continuous perfusion and aspiration for at least 30 minutes to achieve steady state conditions, four 15-minute collections were made during the basal period. This was followed by seven 15-minute collections, after the subcutaneous injection of betazole (1.5 mg/kg body weight). The results were expressed as basal acid output (mmol of acid secreted per one hour) and maximal acid output (mmol/h) obtained by doubling the outputs during the two highest consecutive 15-minute periods after betazole administration. Therefore, in each patient, two basal secretion measurements were performed on different days: (Dixon and Massey, 1969) . Mean relative difference of basal outputs in duplicate studies was calculated by the formula: 1st study-2nd study x 100 mean of two studies
Results
The fasting, postprandial, and post-betazole acid outputs of each patient are shown by Figs. 1 and 2 . In the patients with higher fasting acid output (cases 1, 3, 4, and 6), ingestion of the meal caused a profound decrease in acid output, which returned to basal levels later in the postprandial period. In these patients (except for case 1), the basal and 'maximal' post-betazole acid outputs were similar. In the two other gastrinoma patients (cases 2 and 5), the fasting acid output was much lower and ingestion of the meal produced an early increase in acid output which was similar to their post-betazole 'maximal' acid outputs (well above basal outputs). Later, during the second or third postprandial hours, transient decreases in acid output below the fasting rate were noted in each patient. For the six patients considered as group (Table 3) , the average postprandial acid output was 46-3 % lower than the basal output (p < 0 05), whereas the average peak postprandial output did not differ significantly from basal. The secretory volume output paralleled the acid output and therefore little change between the fasting and postprandial acid/volume output ratios was noted (Table 3) . The pepsin output also decreased transiently after the meal but, in contrast to the acid and secretory volume output, the peak postprandial pepsin output was significantly higher than the basal output (p < 0 05). The acid/pepsin output ratio fell correspondingly.
The intragastric pH increased after ingestion of the meal and gradually returned over a period of two hours to fasting values (Fig. 3 ). The titratable acidity followed an almost reciprocal pattern (Fig.  3) . There was no relationship between the postprandial serum gastrin concentration, which remained similar to or even higher than fasting levels (Table 1) , and the change in gastric acid output.
In the two patients who were restudied postoperatively, the fasting gastric acid output decreased profoundly (Fig. 1) . This was accompanied by restoration of a normal gastrin and secretory response to the meal (Fig. 1) and by a marked decrease in fasting and postprandial acid/pepsin ratios (Table 3) .
Discussion
To our knowledge, inhibition of gastric acid output by food in patients with the Zollinger-Ellison syndrome due to gastrinoma has not been previously reported. This observation has several pathophysiological and clinical implications.
Ingestion of the meal in all gastrimona patients with marked basal hypersection (cases 1, 3, 4, and 6) produced marked inhibition of gastric acid and secretory outputs. Invariably, however, the gastric The mechanism of meal-induced inhibition of hours passed before mean postprandial gastric acid output in the Z-E syndrome due to Pasal(fasting) levels. gastrinoma remains speculative, particularly since neurohormonal mechanisms responsible for physiological postprandial acid-inhibitory feedback remain *eturned later in the postprandial largely undefined. Food-triggered inhibitory mechting rate, suggesting that whichever anisms apparently antagonised the stimulatory ts were triggered by food were action of gastrin on parietal cells, because serum sent only while the bulk of the meal immunoreactive gastrin concentrations (reflecting -gastrointestinal tract undergoing near autonomous neoplastic gastrin secretion) did sorption. Further, in most of these not decrease postprandially. The strength of these gastric acid outputs approximated inhibitory forces was such that, at times, postbetazole) secretory rates suggesting prandial acid outputs before and after excision of -hs (as it has been described in other the tumour were similar in contrast to the large astrinoma) differences observed in fasting acid output (Fig. 1) . iaximally' stimulated, making the Oftheknown neurohormonal inhibitory mechanisms, d after the meal even more remark-those elicited by food components, particularly fat-released 'enterogastrones' (Johnson and Gross- )f gastric secretory response to a man, 1971), are the most likely ones for explaining n these patients with gastrinoma is the net inhibitory effect caused by the meal in our that found under similar experi-patients with gastrinoma, because they could be Is in healthy individuals (Malagelada expected to operate postprandially counterbalancing a patients with normogastrinaemic, the continuous stimulus provided by the hyper-,nal ulcer Malagelada et al., 1977) . Consequently, despite much higher interprandial gastric secretory rates, early postcibal acidity in some patients with Z-E syndrome resembles that found in idiopathic duodenal ulcer. Benefits from meal-induced inhibition of gastric acid output received by the unoperated, metabolically compensated patient with gastrinoma may help in explaining the maintenance of body weight or the excess body weight observed in our patients. 
